A novel multivalent tuberculosis vaccine confers protection in a mouse model of tuberculosis

  • Kristin L. Griffiths
  • , Daniel O. Villarreal
  • , David B. Weiner
  • , Shabaana A. Khader

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Mycobacterium tuberculosis infects one third of the world's population. Due to variable efficacy of the Bacille Calmette Guerin (BCG) vaccine, development of novel TB vaccines remains a priority. Here, we demonstrate the protective efficacy of a novel multivalent DNA vaccine, which contains 15 synthetic antigens targeting the Mtb ESX secretion system.

Original languageEnglish
Pages (from-to)2649-2653
Number of pages5
JournalHuman Vaccines and Immunotherapeutics
Volume12
Issue number10
DOIs
StatePublished - Oct 2 2016

Keywords

  • DNA vaccine
  • Tuberculosis
  • vaccine

Fingerprint

Dive into the research topics of 'A novel multivalent tuberculosis vaccine confers protection in a mouse model of tuberculosis'. Together they form a unique fingerprint.

Cite this